
Nicholas Reder
@rederreder
CEO of Alpenglow Biosciences. accelerating drug development with 3D spatial biology.
ID: 557226594
http://www.alpenglowbiosciences.com 18-04-2012 19:25:23
803 Tweet
559 Followers
571 Following

🌟Speaker's Bio Insights! Join us as we dive into Dr. Andrew H. Song’s Andrew H. Song groundbreaking work in AI-based 3D computational pathology at the 3D Spatial Summit on October 17th! Register now to attend his talk! 🎟️alpenglowbiosciences.com/2024-3d-spatia…


🚨Speaker Alert! Nathan Silberman, PhD, VP of Machine Learning at Artera, Inc., joins our 3D Spatial Summit lineup! Plus, Nicholas Reder, MD, CEO of Alpenglow Biosciences, will share insights on 3D pathology. 🚀 Final reveal tomorrow! 🔗 Register now! alpenglowbiosciences.com/2024-3d-spatia…





Come join us #SITC24! Featuring our new work in investigating the melanoma neoadjuvant ICB TME by multimodal MERFISH, computational pathology & 3D light sheet imaging. Also abstract #114 @ Immune Engineering Workshop! Sam @jeffgenome Moffitt Cancer Center Vizgen Alpenglow Biosciences

Thank you Alpenglow Biosciences for hosting this dinner lecture! I had a fantastic time discussing neoadjuvant tumor microenvironment in 2D and 3D with your enthusiastic guests ! And absolutely thrilled to reconnect with Jorge Blando from my postdoc days😊!! Moffitt Cancer Center


Excited to share our work on determinants of prostate organization and castration resistance using single-cell and spatial omics, bit.ly/4guRPab. Great working with EvanKeller, Arul Chinnaiyan and MCTP. Michigan Urology Michigan Pathology Michigan Medicine U-M Rogel Cancer Center PCF Science

🎉 Happy New Year! After the New Year countdown, we’re starting 2025 strong—just 10 days until January 12, when our CEO, Nicholas Reder, Nicholas Reder, MD, MPH, speaks at the Dermatology Summit! Don’t miss insights on cutting-edge applications of 3D spatial biology in dermatology!



Thank you Nicholas Reder for the amazing 3D Spatial Biology seminar Moffitt Cancer Center! We were blown away by your cutting-edge technology and high resolution 3D Path imaging paired with AI driven analysis! Made my day! "Using 3D Spatial Biology to Advance Cancer Research" Alpenglow Biosciences


Alpenglow Biosciences is committed to scientific innovation despite fiscal uncertainty. CEO Nick Reder discusses on The Washington Post how NIH funding cuts could impact research. We continue to push the boundaries of science to improve patient outcomes. Read: shorturl.at/KhsUm





I shared my thoughts in a Nature Medicine comment on the urgent need for more standardized benchmarks in #AI for biomedicine. nature.com/articles/s4159…


